Krsnaa Diagnostics is currently trading at Rs. 542.00, up by 1.95 points or 0.36% from its previous closing of Rs. 540.05 on the BSE.
The scrip opened at Rs. 548.80 and has touched a high and low of Rs. 551.00 and Rs. 541.80 respectively. So far 4607 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 1099.50 on 16-Aug-2021 and a 52 week low of Rs. 480.00 on 31-Mar-2022.
Last one week high and low of the scrip stood at Rs. 559.00 and Rs. 524.50 respectively. The current market cap of the company is Rs. 1705.20 crore.
The promoters holding in the company stood at 27.38%, while Institutions and Non-Institutions held 33.13% and 39.49% respectively.
Krsnaa Diagnostics has secured an order from Office of the Medical Director, India Gandhi Hospital, Government of NCT of Delhi. The order is for establishment, operation and management of Radiology Unit (for providing MRI and CT Scan services) in the Department of Radiology in the premises of Indira Gandhi Hospital, Dwarka in Delhi on Public Private Partnership (PPP) basis. With this order the company now has its footprints in the capital of India. The tenure of contract will be upto 12 years from date of signing the Contract / installation.
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: